Quick answer
Johnson & Johnson (JNJ) reported earnings of $2.59 per share for the quarter ended Sep 2026 on Oct 13, 2026, which beat the $2.53 consensus forecast by 2.4%. The stock closed -5.7% on the report day ($248.61 vs $263.73 the session before) and is -3.1% through Oct 16, 2026.
EPS (Sep 2026)$2.59
Consensus$2.53
Surprise+2.4%
Report-day move-5.7%
EPS vs consensus, last four quarters
| Quarter ended | Reported | EPS | Consensus | Surprise |
|---|---|---|---|---|
| Sep 2026 | 10/13/2026 | $2.59 | $2.53 | +2.4% |
| Jun 2026 | 7/15/2026 | $2.90 | $2.84 | +2.1% |
| Mar 2026 | 4/14/2026 | $2.70 | $2.67 | +1.1% |
| Dec 2025 | 1/21/2026 | $2.46 | $2.43 | +1.2% |
JNJ beat the consensus EPS forecast in 4 of the last 4 quarters (Nasdaq / Zacks data).
Revenue by quarter (SEC XBRL, RevenueFromContractWithCustomerExcludingAssessedTax)
| Quarter | Revenue | Year earlier | YoY | Filing |
|---|---|---|---|---|
| Dec 30, 2024 – Mar 30, 2025 | $21.89B | $21.38B | +2.4% | 10-Q filed Apr 22, 2026 |
| Mar 31, 2025 – Jun 29, 2025 | $23.74B | $22.45B | +5.8% | 10-Q filed Jul 23, 2026 |
| Jun 30, 2025 – Sep 28, 2025 | $23.99B | $22.47B | +6.8% | 10-Q filed Oct 22, 2025 |
| Dec 29, 2025 – Mar 29, 2026 | $24.06B | $21.89B | +9.9% | 10-Q filed Apr 22, 2026 |
| Mar 30, 2026 – Jun 28, 2026 | $25.31B | $23.74B | +6.6% | 10-Q filed Jul 23, 2026 |
Diluted EPS as filed with the SEC
| Quarter | Diluted EPS | Filing |
|---|---|---|
| Dec 30, 2024 – Mar 30, 2025 | $4.54 | 10-Q filed Apr 22, 2026 |
| Mar 31, 2025 – Jun 29, 2025 | $2.29 | 10-Q filed Jul 23, 2026 |
| Jun 30, 2025 – Sep 28, 2025 | $2.12 | 10-Q filed Oct 22, 2025 |
| Dec 29, 2025 – Mar 29, 2026 | $2.14 | 10-Q filed Apr 22, 2026 |
| Mar 30, 2026 – Jun 28, 2026 | $2.27 | 10-Q filed Jul 23, 2026 |
SEC XBRL figures come from 10-Q/10-K filings, so the newest quarter appears only after the 10-Q is filed; reported quarterly values only (no derived Q4).
Stock reaction
| Date | Close | Change vs pre-report close | |
|---|---|---|---|
| Session before report | Oct 12, 2026 | $263.73 | – |
| Report day | Oct 13, 2026 | $248.61 | -5.73% |
| Next session | Oct 14, 2026 | $253.91 | -3.72% |
Nasdaq does not always state whether the report came before the open or after the close, so both the report-day and next-session moves are shown.
Sources
- SEC XBRL: Johnson & Johnson RevenueFromContractWithCustomerExcludingAssessedTax (latest filing Jul 23, 2026)
- SEC XBRL: Johnson & Johnson diluted EPS (latest filing Jul 23, 2026)
- SEC EDGAR: Johnson & Johnson Form 8-K (earnings release), Items 2.02,9.01 (filed Oct 13, 2026)
- Nasdaq: JNJ earnings surprise history and next date (retrieved Oct 19, 2026)
- Nasdaq: JNJ historical prices (through Oct 16, 2026 close)